| 12.00 Delayed Data As of Aug 21 |  +0.25 / +2.13%Today’s Change | 6.50 Today|||52-Week Range 25.10 | +15.50% Year-to-Date |
| Previous close | 11.75 |
| Today’s open | 11.85 |
| Day’s range | 11.71 - 12.25 |
| Volume | 3,527,946 |
| Average volume (3 months) | 4,946,548 |
| Market cap | $4.1B |
| Earnings growth (last year) | -651.95% |
| Earnings growth (this year) | +778.22% |
| Earnings growth (next 5 years) | +11.54% |
| Revenue growth (last year) | +80.42% |
| P/E ratio | 33.8 |
| Price/Sales | 319.68 |
| Price/Book | 13.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| ARGXargenx SE | +1.52 | +1.11% |
| ACBAurora Cannabis Inc | -0.09 | -1.52% |
| APHAAphria Inc | +0.33 | +5.28% |
| USNAUSANA Health Science... | +0.50 | +0.75% |
| Next reporting date | November 27, 2019 |
| EPS forecast (this quarter) | -$0.02 |
| Annual revenue (last year) | $5.7M |
| Annual profit (last year) | -$14.6M |
| Net profit margin | -257.95% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Michael Gorenstein |
Chief Operating Officer David Hsu |
Corporate headquarters Toronto, Ontario |
